Congenital heart disease
-
Congenital heart disease · Jul 2011
Survival and morbidity following congenital heart surgery in a population-based cohort of children--up to 12 years of follow-up.
The Risk Adjusted Classification for Congenital Heart Surgery can predict early mortality. However, the relation to long-term outcome in terms of mortality and morbidity is unknown. ⋯ Children operated for congenital heart disease have impaired survival and often undergo new operations or catheter-based interventions. The risk of these events is related to the surgical complexity according to the Risk Adjusted Classification for Congenital Heart Surgery.
-
Congenital heart disease · Jul 2011
Impact of pharmacotherapy on interstage outcomes in single ventricle infants.
To characterize the pharmacotherapeutic regimens used in infants with single ventricle heart disease and determine the influence of outpatient medications on interstage weight gain. ⋯ Infants with single ventricle heart disease have a high-medication burden during the interstage period. Despite the focused and intensified use of medications to improve feeding tolerance and somatic growth, current pharmacotherapeutic regimens appear to have little effect on interstage weight gain.